Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
Harvard Bioscience (Nasdaq: HBIO) will announce its Q1 2021 financial results on May 6, 2021, before market opening. A conference call will follow at 8:00 a.m. ET for discussions on the earnings report. Investors can participate by calling toll-free 1 (877) 303-7611 or internationally at 1 (970) 315-0445, using conference ID # 5876756. The call will also be available via webcast on Harvard Bioscience's website. The company specializes in technologies and products for research and drug development, serving a global client base.
- Scheduled Q1 2021 earnings announcement, indicating ongoing business activity.
- Conference call for direct investor engagement, promoting transparency.
- None.
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 5876756.
The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Investor Contact
Michael Rossi
Chief Financial Officer
(508) 893-8999
mrossi@harvardbioscience.com
FAQ
When will Harvard Bioscience announce its Q1 2021 financial results?
What time is the Harvard Bioscience conference call for Q1 2021 results?
How can I access the Harvard Bioscience Q1 2021 earnings call?